How to Architect an AI-Driven Target Identification Platform

An AI-driven target identification platform is a production-grade software system that automates the discovery of novel drug targets. Its core function is to integrate multi-omics data—genomic, proteomic, transcriptomic—into a unified data lake, apply machine learning models to uncover biological patterns, and prioritize candidates for experimental validation. The architecture must be cloud-native and API-first, enabling computational biologists to submit hypotheses and retrieve results programmatically. Key components include scalable data ingestion pipelines, a microservices-based API layer, and model serving infrastructure using tools like vLLM or Amazon SageMaker.

Successful implementation requires designing for continuous hypothesis generation. This means establishing automated feedback loops where wet lab validation results are used to retrain and improve AI models. You must architect separate but connected systems for data management, model inference, and workflow orchestration. A practical first step is to define your data integration strategy and establish a secure data lake. This foundation supports downstream tasks like building a knowledge graph for drug target relationships and implementing a robust target prioritization framework.